HighVista Strategies LLC

Position in EWTX — Edgewise Therapeutics, Inc.

CIK 1335325 BOSTON, MA

Position in EWTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,697,167

+$801,341 QoQ

Shares Held

90,996

-1.0% QoQ

Ownership

0.084%

of shares outstanding

% of Portfolio

0.84%

of 13F equity value

Holder Rank

#76

of 223 holders

Holding Since

Jun 2021

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HighVista Strategies LLC holds $278,365,756 across 70 Biotechnology names. EWTX ranks #32 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	113,031	$15,062,511
2	RVMD	Revolution Medicines, Inc.	66,983	$12,544,576
3	DFTX	Definium Therapeutics, Inc.	242,884	$11,425,263
4	IMVT	Immunovant, Inc.	277,873	$10,706,446
5	PRAX	Praxis Precision Medicines, Inc.	30,210	$10,114,005
6	RLAY	Relay Therapeutics, Inc.	506,235	$9,471,656
7	PCVX	Vaxcyte, Inc.	149,739	$8,704,328
8	TNGX	Tango Therapeutics, Inc.	260,070	$8,129,788

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,697,167	90,996	-1.0%	Shares	Sole	2026-08-14
2026-03-31	$2,895,826	91,931	-46.3%	Shares	Sole	2026-05-15
2025-12-31	$4,246,764	171,137	-17.8%	Shares	Sole	2026-02-17
2025-09-30	$3,375,398	208,101	+198.5%	Shares	Sole	2025-11-14
2025-06-30	$914,068	69,723	-23.6%	Shares	Sole	2025-08-14
2025-03-31	$2,006,554	91,207	+10.2%	Shares	Sole	2025-05-15
2024-12-31	$2,208,944	82,732	-6.9%	Shares	Sole	2025-02-14
2024-09-30	$2,371,086	88,838	-52.6%	Shares	Sole	2024-11-14
2022-12-31	$1,676,071	187,480	+81.2%	Shares	Sole	2023-02-14
2022-09-30	$1,018,066	103,462	0.0%	Shares	Sole	2022-11-14
2022-06-30	$823,557	103,462	+73.2%	Shares	Sole	2022-08-15
2022-03-31	$579,410	59,733	+52.6%	Shares	Sole	2022-05-16
2021-09-30	$649,607	39,133	+42.5%	Shares	Sole	2021-11-15
2021-06-30	$585,871	27,467	—	Shares	Sole	2021-08-16
No filing history on record for this holder in this stock.